Integrating Emerging Evidence into the Management of Patients with Chronic Lymphocytic Leukemia (satellite symposium)
The goal of this activity is to improve the ability to optimize therapy and incorporate clinical advances into the management of patients with chronic lymphocytic leukemia.
This program is intended for physicians, registered nurses, pharmacists, and other health care professionals who provide care for patients with hematologic malignancies.
Upon completion of this activity, participants should be able to:
- Select optimal treatment for patients with newly diagnosed chronic lymphocytic leukemia based on patient-specific and disease-specific factors
- Choose optimal treatment for relapsed/refractory chronic lymphocytic leukemia in special patient populations
- Explain how promising investigational agents may fit into the current treatment paradigm for chronic lymphocytic leukemia
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
- 1.00 Participation
- 1.00 Nurse
- 1.00 Pharmacist
- 1.00 Physician